Genomic analysis identifies micro RNA (miR-506) opponent for ovarian cancer - National Cancer Institute Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, February 13, 2013

Genomic analysis identifies micro RNA (miR-506) opponent for ovarian cancer - National Cancer Institute



Genomic analysis identifies micro RNA opponent for ovarian cancer - National Cancer Institute

NCI Cancer Center News

Deep genomic analysis identifies a micro RNA opponent for ovarian cancer

Researchers led by MD Anderson Cancer Center employed an extensive analysis of genomic information to identify a new, high-risk cohort of ovarian cancer patients, characterize their tumors, find a potential treatment and test it in mouse models of the disease. The exhaustive analysis that led to micro RNA 506 (miR-506) as a potential therapeutic candidate for advanced or metastatic ovarian cancer is the cover article in the Feb. 11 edition of Cancer Cell.
Click here to read full press release Exit Disclaimer.

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.